Arcus Biosciences Inc (RCUS)

Total asset turnover

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Revenue (ttm) US$ in thousands 258,000 263,000 247,000 237,000 117,000 119,355 121,236 118,995 112,000 433,144 408,724 399,137 398,304 53,292 108,361 92,939 77,517 77,780 15,000 15,000
Total assets US$ in thousands 1,150,000 1,252,000 1,186,000 1,293,000 1,095,000 1,191,000 1,220,000 1,254,000 1,345,000 1,393,820 1,476,770 1,543,430 1,592,000 839,290 898,773 935,119 772,292 811,075 481,389 176,144
Total asset turnover 0.22 0.21 0.21 0.18 0.11 0.10 0.10 0.09 0.08 0.31 0.28 0.26 0.25 0.06 0.12 0.10 0.10 0.10 0.03 0.09

December 31, 2024 calculation

Total asset turnover = Revenue (ttm) ÷ Total assets
= $258,000K ÷ $1,150,000K
= 0.22

The total asset turnover ratio for Arcus Biosciences Inc shows fluctuations over the analyzed period. The ratio increased from 0.09 in March 2020 to 0.28 in June 2022, indicating an improvement in how efficiently the company generates sales from its total assets. However, the ratio declined to 0.08 by December 2022 and then showed further fluctuations in subsequent quarters, ranging between 0.09 and 0.22.

Overall, the company's total asset turnover ratio demonstrates variability in its asset utilization efficiency. It is essential for stakeholders to monitor this ratio closely as it provides insights into the company's ability to generate revenue from its assets and manage its resources effectively.